Order Article Reprints

Vogel J-U, Schmidt S, Schmidt D, Rothweiler F, Koch B, Baer P, Rabenau H, Michel D, Stamminger T, Michaelis M, et al. The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron Chelation. Cells. 2020; 9(1):31. https://doi.org/10.3390/cells9010031

Vogel, Jens-Uwe, Sophie Schmidt, Daniel Schmidt, Florian Rothweiler, Benjamin Koch, Patrick Baer, Holger Rabenau, Detlef Michel, Thomas Stamminger, Martin Michaelis, and et al. 2020. "The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron Chelation" Cells 9, no. 1: 31. https://doi.org/10.3390/cells9010031

Vogel, J.-U., Schmidt, S., Schmidt, D., Rothweiler, F., Koch, B., Baer, P., Rabenau, H., Michel, D., Stamminger, T., Michaelis, M., & Cinatl, J. (2020). The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron Chelation. Cells, 9(1), 31. https://doi.org/10.3390/cells9010031